“MHC Class I-Presented Tumor Antigen Appraisable for T-Cell Responses Against Ovarian Cancer”. Bangladesh Journal of Pharmacology, vol. 10, no. 3, July 2015, pp. 524-8, https://doi.org/10.3329/bjp.v10i3.23076.